1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Pain relief with oral cannabinoids in familial Mediterranean fever [1997]

Pain relief with oral cannabinoids in familial Mediterranean fever [1997]

  1. Behrang
    Anaesthesia Volume 52, Issue 5, Pages 483-8, Article first published online: 5 JAN 2004

    A. Holdcroft, M. Smith, A. Jacklin, H. Hodgson, B. Smith, M. Newton, and F. Evans

    Abstract:
    Cannabinoids have analgesic and, possibly, anti-inflammatory properties but their clinical use has been restricted by legislation. This is the first United Kingdom report of the controlled use of a standardised pharmaceutical preparation of cannabinoids in capsular form. The therapy was assessed in a patient with familial Mediterranean fever, who presented with chronic relapsing pain and inflammation of gastrointestinal origin. After determining a suitable analgesic dosage, a double-blind placebo-controlled cross-over trial was conducted using 50 mg tetrahydrocannabinol daily in five doses in the active weeks and measuring effects on parameters of inflammation and pain. Although no anti-inflammatory effects of tetrahydrocannabinol were detected during the trial, a highly significant reduction (p < 0.001) in additional analgesic requirements was achieved. Future study designs can now incorporate prescribable forms of cannabinoids but the choice of previous cannabis users only as patients has clinical limitations. Cannabis naive patients would tolerate controlled investigations but may generate medicolegal problems.

    Keywords:
    Complications; familial Mediterranean fever. Pain; management. Pharmacology; tetrahydrocannabinol

    http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2044.1997.139-az0132.x/pdf